Market Cap (In JPY)
18.88 Billion
Revenue (In JPY)
269.49 Million
Net Income (In JPY)
-763.74 Million
Avg. Volume
542.4 Thousand
- Currency
- JPY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 229.0-602.0
- PE
- -
- EPS
- -
- Beta Value
- 1.114
- ISIN
- JP3399680002
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Koki Uehara
- Employee Count
- -
- Website
- https://www.stella-pharma.co.jp
- Ipo Date
- 2021-04-22
- Details
- Stella Pharma Corporation engages in the research, development, manufacturing, and distribution of pharmaceuticals. The company develops drugs for boron neutron capture therapy (BNCT). Its product includes SPM-011, a boron-containing drug for BNCT used for treating head and neck cancer, recurrent malignant glioma and meningioma, and malignant melanoma and angiosarcoma. The company was incorporated in 2007 and is headquartered in Osaka, Japan.
More Stocks
-
CBSH
-
3695
-
603318Shuifa Energas Gas Co., Ltd.
603318
-
2156
-
3649FINDEX Inc.
3649
-
TKC
-
0Z62
-
GOEVCanoo Inc.
GOEV